Product NDC: | 58914-170 |
Proprietary Name: | Carafate |
Non Proprietary Name: | Sucralfate |
Active Ingredient(s): | 1 g/10mL & nbsp; Sucralfate |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58914-170 |
Labeler Name: | Aptalis Pharma Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019183 |
Marketing Category: | NDA |
Start Marketing Date: | 19931216 |
Package NDC: | 58914-170-14 |
Package Description: | 414 mL in 1 BOTTLE (58914-170-14) |
NDC Code | 58914-170-14 |
Proprietary Name | Carafate |
Package Description | 414 mL in 1 BOTTLE (58914-170-14) |
Product NDC | 58914-170 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sucralfate |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 19931216 |
Marketing Category Name | NDA |
Labeler Name | Aptalis Pharma Inc. |
Substance Name | SUCRALFATE |
Strength Number | 1 |
Strength Unit | g/10mL |
Pharmaceutical Classes | Aluminum Complex [EPC],Organometallic Compounds [Chemical/Ingredient] |